Profound Medical Inc. Treatment System


********

Profound’s Solution

Arguably the best medical imaging tool in common use today, Magnetic Resonance Imaging (MRI) enables a clinician to "see" in detail the internal organs of a patient non-invasively. Ultrasound imaging and thermal coagulation therapy have proven utility in several medical applications. When combining the two methodologies, the opportunity exists for an optimal and vastly superior clinical outcome. Profound Medical Inc (PMI) has developed a novel MRI-compatible ultrasound applicator to deliver controlled thermal therapy to the cancerous regions of the prostate gland via a trans-urethral approach. The prototype has been extensively tested and delivered consistent and predictable proof-of-concept results in mathematical, gel, and most recently pre-clinical models.

Features and Benefits

PMI has invented and developed a complete system for the clinical urologist and oncologist that enables:

Complete compatibility within an MRI suite
Accurate location of the trans-urethral ultrasound applicator in the prostate
Multiple 3D treatment planning options through proprietary software
Precise heating control through unique array geometries and frequencies
Whole or segmented treatments relative to disease progression and location
Single or multiple treatments in the same session
Real-time thermometry for active monitoring and surveillance
Highest control around organs such as nerve bundles, rectum & urethra
Treatment time estimates of 30 mins (6X faster than next best)

The company is accelerating development of the system to "clinical grade" in anticipation of human clinical trials in Canada and USA in the near future.